Integrated bioinformatics analysis identifies established and novel TGFβ1-regulated genes modulated by anti-fibrotic drugs

[1]  M. Zhang,et al.  The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1 , 2021, Science advances.

[2]  Y. Gan,et al.  Pharmaceutical targeting of succinate dehydrogenase in fibroblasts controls bleomycin-induced lung fibrosis , 2021, Redox biology.

[3]  Mark G. Jones,et al.  Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. , 2020, Pharmacology & therapeutics.

[4]  G. Washko,et al.  Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. , 2020, Science advances.

[5]  S. Hirakawa,et al.  Potential role of transforming growth factor‐beta 1/Smad signaling in secondary lymphedema after cancer surgery , 2020, Cancer science.

[6]  T. Luckhardt,et al.  Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis , 2020, Drug, healthcare and patient safety.

[7]  J. Cortijo,et al.  Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation , 2020, Oncotarget.

[8]  Sun Wook Cho,et al.  Multifaceted Actions of Succinate as a Signaling Transmitter Vary with Its Cellular Locations , 2020, Endocrinology and metabolism.

[9]  S. Majewski,et al.  Epithelial Alarmins in Serum and Exhaled Breath in Patients with Idiopathic Pulmonary Fibrosis: A Prospective One-Year Follow-Up Cohort Study , 2019, Journal of clinical medicine.

[10]  M. Peters-Golden,et al.  Molecular determinants of mesenchymal cell activation in fibroproliferative diseases , 2019, Cellular and Molecular Life Sciences.

[11]  Y. Kondoh,et al.  Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF). , 2019, Journal of thoracic disease.

[12]  K. Ikeo,et al.  Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1 , 2019, Respiratory Research.

[13]  K. Schenke-Layland,et al.  Cardiac fibrosis - A short review of causes and therapeutic strategies. , 2019, Advanced drug delivery reviews.

[14]  V. Thannickal,et al.  The Aging Lung and Idiopathic Pulmonary Fibrosis. , 2019, The American journal of the medical sciences.

[15]  Rainer Schneider,et al.  A Unique Family of Neuronal Signaling Proteins Implicated in Oncogenesis and Tumor Suppression , 2019, Front. Oncol..

[16]  Si-jia Chen,et al.  Micheliolide ameliorates renal fibrosis by suppressing the Mtdh/BMP/MAPK pathway , 2019, Laboratory Investigation.

[17]  T. Suda,et al.  The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype , 2018, European Respiratory Review.

[18]  M. Cho,et al.  Suppression of Cavernosal Fibrosis in a Rat Model. , 2018, Sexual medicine reviews.

[19]  W. Seeger,et al.  Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis , 2018, European Respiratory Journal.

[20]  Eun-Hee Cho.  Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis , 2018, Front. Endocrinol..

[21]  D. Sheppard,et al.  TGF-β1 Signaling and Tissue Fibrosis. , 2018, Cold Spring Harbor perspectives in biology.

[22]  R. Lockey,et al.  The dawn of succinylation: a posttranslational modification. , 2018, American journal of physiology. Cell physiology.

[23]  L. Richeldi,et al.  Nintedanib for the treatment of idiopathic pulmonary fibrosis , 2018, Expert opinion on pharmacotherapy.

[24]  Jacob K. Asiedu,et al.  The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.

[25]  N. Sandbo,et al.  Tensin 1 Is Essential for Myofibroblast Differentiation and Extracellular Matrix Formation , 2017, American journal of respiratory cell and molecular biology.

[26]  P. Shi,et al.  miR-21 enhances cardiac fibrotic remodeling and fibroblast proliferation via CADM1/STAT3 pathway , 2017, BMC Cardiovascular Disorders.

[27]  W. Grizzle,et al.  Surveying the serologic proteome in a tissue‐specific kras(G12D) knockin mouse model of pancreatic cancer , 2016, Proteomics.

[28]  S. Plymate,et al.  Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression , 2016, Hormones and Cancer.

[29]  V. Thannickal,et al.  Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now? , 2016, Drugs.

[30]  C. Lim,et al.  Mesothelial cells in tissue repair and fibrosis , 2015, Front. Pharmacol..

[31]  D. Kang,et al.  Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells , 2015, Kidney research and clinical practice.

[32]  A. Ganser,et al.  Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction , 2015, Nature Medicine.

[33]  David S. Wishart,et al.  T3DB: the toxic exposome database , 2014, Nucleic Acids Res..

[34]  A. Gaggar,et al.  Fibrosis: ultimate and proximate causes. , 2014, The Journal of clinical investigation.

[35]  L. Leinwand,et al.  Roles of transforming growth factor‐β1 and OB‐cadherin in porcine cardiac valve myofibroblast differentiation , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  N. Laird,et al.  A comparative analysis of family-based and population-based association tests using whole genome sequence data , 2014, BMC Proceedings.

[37]  H. Collard,et al.  Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. , 2014, American journal of respiratory and critical care medicine.

[38]  P. Bradding,et al.  CADM1 Is a Key Receptor Mediating Human Mast Cell Adhesion to Human Lung Fibroblasts and Airway Smooth Muscle Cells , 2013, PloS one.

[39]  L. Feuk,et al.  Diagnostic interpretation of array data using public databases and internet sources , 2012, Human mutation.

[40]  Minghua Wu,et al.  Cadherin‐11 contributes to pulmonary fibrosis: potential role in TGF‐β production and epithelial to mesenchymal transition , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[42]  Daniel R. Salomon,et al.  Strategies for aggregating gene expression data: The collapseRows R function , 2011, BMC Bioinformatics.

[43]  F. Martinez,et al.  NADPH Oxidase-4 Mediates Myofibroblast Activation and Fibrogenic Responses to Lung Injury , 2009, Nature Medicine.

[44]  S. Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[45]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[46]  J. Adamski,et al.  Multifunctionality of human 17β-hydroxysteroid dehydrogenases , 2006, Molecular and Cellular Endocrinology.

[47]  F. Martinez,et al.  Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. , 2005, The American journal of pathology.

[48]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[49]  Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.

[50]  Arthur Liberzon,et al.  A description of the Molecular Signatures Database (MSigDB) Web site. , 2014, Methods in molecular biology.

[51]  S. Rosselot.  Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[52]  J. Adamski,et al.  Multifunctionality of human 17beta-hydroxysteroid dehydrogenases. , 2006, Molecular and cellular endocrinology.